Analysts have clear opinions on OSUR.

OraSure Technologies, Inc. (OSUR) is followed by analysts on the street.

Mark Massaro from Canaccord Genuity rates it a Hold with a target of $8.00.

Similarly, null null of null null a null with a target of null.

The consensus on the street is null.

What does OraSure Technologies, Inc.(OSUR) do ?
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

OraSure Technologies, Inc. (OSUR) Insider Trades

Looking for stocks just like OSUR?

Based on Wall Street analyst research, several stocks are similar to OSUR
They are:
– CEMI [Info can be found here: ]
– TMO [Info can be found here: ]
– QDEL [Info can be found here: ]